News

Cantonal bank awards start-up prize

St.Galler Kantonalbank has awarded its start-up prize. The winner of the Startfeld Diamant 2020 is matriq AG based in St.Gallen. The company develops coding and marking solutions for plastic products.

Klaus Dietrich, CTO and André Bernard, CEO Matriq AG
Klaus Dietrich, CTO and André Bernard, CEO Matriq AG. Image Credit: SGKB

matriq AG is the winner of this year’s start-up prize awarded by St.Galler Kantonalbank (SGKB). According to a press release, the St.GallenBodenseeArea start-up founded in 2019 has been presented with the Startfeld Diamant prize for its customize watermark solution developed for plastic products. This ensures traceability, anti-counterfeit protection and security for these plastic parts.

To this end, the Dynamic Mold solution developed and patented by matriq is integrated in the respective manufacturing process, via which each plastic component is stamped with an individual serial number in the form of a 2D code. Roland Ledergerber, Jury President for the Startfeld Diamant and CEO of SGKB, was quoted in the press release: “matriq AG has come up with a simple solution to a real problem. Thanks to their product protection system, the company offers manufacturers of plastic parts traceability and anti-counterfeit protection that is simpler, cheaper and more secure than conventional methods”.

In addition to matriq AG, which was founded by four researchers from the Interstate University of Technology Buchs (NTB), Gossik from Wittenbach SG was another award-winning firm. Also based in St.Gallen, Gossik has developed a productivity app that was awarded the public prize. In addition, four other start-ups made it to the final where they eventually had to concede victory to matriq AG. These companies included the IT firm actesy AG from St.Gallen, Talentwerk AG from St.Gallen, whose products help users with networking, Vivatum PD AG from Eschenbach SG, a company that operates in the field of healthcare with the aim of modernizing and digitalizing peritoneal dialysis, and Stromal Therapeutics AG based in St.Gallen, which is developing “immunotherapeutic antibodies for the treatment of cancer and chronic inflammatory diseases”.

Handbook for Investors

Our Handbook for Investors provides valuable information about technologies and production costs, taxes and financing, as well as the legal system and infrastructure in Switzerland. Browse through the complete handbook online or download the chapters most relevant to you.

Share

Official program